Barclays
INVA icon

Barclays’s Innoviva INVA Stock Holding History

Barclays’s Portfolio INVA Stock Details INVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-300
Closed -$5K – 7156
2018
Q4 		$5K Sell
300
-600
-67% -$9.74K ﹤0.01% 6438
2018
Q3 		$14K Sell
900
-200
-18% -$2.88K ﹤0.01% 6561
2018
Q2 		$15K Buy
1,100
+400
+57% +$5.99K ﹤0.01% 6336
2018
Q1 		$12K Buy
700
+600
+600% +$9.26K ﹤0.01% 6601
2017
Q4 		$1K Hold
100
– – ﹤0.01% 6843
2017
Q3 		$1K Buy
+100
New +$1.32K ﹤0.01% 6754
2017
Q2 		– Sell
-1,900
Closed -$26K – 6773
2017
Q1 		$26K Sell
1,900
-7,300
-79% -$85.9K ﹤0.01% 5688
2016
Q4 		$98K Hold
9,200
– – ﹤0.01% 4761
2016
Q3 		$101K Sell
9,200
-29,900
-76% -$349K ﹤0.01% 4511
2016
Q2 		$412K Buy
+39,100
New +$463K ﹤0.01% 3364
2016
Q1 		– Sell
-100
Closed -$1K – 6271
2015
Q4 		$1K Sell
100
-500
-83% -$4.6K ﹤0.01% 5827
2015
Q3 		$4K Sell
600
-3,000
-83% -$40.8K ﹤0.01% 6119
2015
Q2 		$65K Sell
3,600
-1,834,500
-100% -$31.5M ﹤0.01% 4984
2015
Q1 		$27.6M Buy
1,838,100
+1,829,500
+21,273% +$27.7M 0.03% 537
2014
Q4 		$120K Buy
8,600
+2,300
+37% +$34.6K ﹤0.01% 5043
2014
Q3 		$107K Sell
6,300
-400
-6% -$9.19K ﹤0.01% 5271
2014
Q2 		$195K Sell
6,700
-98,785
-94% -$2.37M ﹤0.01% 4840
2014
Q1 		$2.55M Buy
105,485
+83,767
+386% +$2.45M ﹤0.01% 2306
2013
Q4 		$613K Sell
21,718
-11,417
-34% -$334K ﹤0.01% 3894
2013
Q3 		$1.07M Buy
33,135
+2,730
+9% +$84.9K ﹤0.01% 3285
2013
Q2 		$944K Buy
+30,405
New +$816K ﹤0.01% 3449

Other funds holding INVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Barclays's INVA Position: Q1 2026 in Review

Barclays reduced its Innoviva (INVA) stake by 27% in Q1 2026, selling an estimated $3.4M and leaving 430,879 shares worth $10M. The position accounts for ﹤0.01% of the portfolio, ranked #1450.

Barclays first reported a position in INVA in Q2 2013 and has held it in 52 quarters since. The position peaked at $11.8M in Q4 2025. 286 funds tracked by Wall St. Rank hold INVA as of Q1 2026.

  • Barclays held 430,879 shares of Innoviva worth $10M as of Q1 2026.
  • Barclays sold 157,650 Innoviva shares in Q1 2026, an estimated $3.4M.
  • Innoviva made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #1450 holding.
  • Barclays first reported a position in Innoviva in Q2 2013 and has held it in 52 quarters since.
  • Barclays's Innoviva position peaked at $11.8M in Q4 2025.
  • 286 funds tracked by Wall St. Rank held Innoviva as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.